US Physical Therapy
USPH · NYSE
About USPH
- Employees
- 6,374
- Headquarters
- Houston, Texas
- Listed
- May 29, 1992
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- usph.com
USPH key statistics
- Market cap
- 1.29B
- Price-earnings ratio
- 466.17
- Dividend yield
- 2.17%
- Average volume
- 177.16K
- Volume
- 177.25K
- Open price
- $84.20
- High today
- $87.17
- Low today
- $84.20
- 52 Week high
- $93.50
- 52 Week low
- $58.19
US Physical Therapy (USPH) at a glance
As of Oct 20, 2026, US Physical Therapy (USPH) shares are priced at $87.02, giving the company a market cap of 1.29B, a price-to-earnings ratio of 466.17 and a dividend yield of 2.17%.
Today the stock has traded between $84.20 and $87.17. The current price is 3.3% above the day's low and 0.2% below its high.
Volume so far is 177.25K shares, in line with the average of 177.16K shares a day.
Over the past year US Physical Therapy has ranged from $58.19 to $93.50, and now sits 82% of the way up that range.
US Physical Therapy met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.75 per share against an estimate of $0.8602.
The average analyst price target is $99.35, 14.2% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $95.95
- Now
- $87.02
- High
- $105.00
USPH earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 10.3% on average.
- Q3 FY24: reported $0.69 per share against an estimate of $0.697
- Q4 FY24: reported $0.65 per share against an estimate of $0.7038
- Q1 FY25: reported $0.48 per share against an estimate of $0.4386
- Q2 FY25: reported $0.81 per share against an estimate of $0.7293
- Q3 FY25: reported $0.66 per share against an estimate of $0.6834
- Q4 FY25: reported $0.67 per share against an estimate of $0.68
- Q1 FY26: reported $0.46 per share against an estimate of $0.5559
- Q2 FY26: reported $0.75 per share against an estimate of $0.8602
USPH news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
- Press releaseBusiness Wire
U.S. Physical Therapy Announces CFO
- Press releaseBusiness Wire
USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance
- Press releaseBusiness Wire
NACD North Texas Announces New Chapter Officers and Board Member for 2026–2027
- Press releaseBusiness Wire
U.S. Physical Therapy, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call Dates
- Press releaseBusiness Wire
U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice
- Press releaseBusiness Wire
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference
Similar companies
Companies in the same industry as US Physical Therapy
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.